Two N-linked sites of glycosylation in the insulin receptor were examined for their contribution to insulin binding, tyrosine kinase activity, and receptor biosynthesis. Asn397 and Asn418 were replaced by Gln using site-directed mutagenesis either as single mutations, i.e., Q-397 and Q-418, or as a double mutation in which both sites were removed (Q-D). The mutations were transiently expressed in COS cells and the findings compared with cells that transiently expressed the wild-type human insulin receptor. Q-397 and Q-418 mutant insulin receptors had insulin-binding characteristics similar to the wild-type human insulin receptor, whereas no insulin-binding activity could be detected above the control level in cells transfected with Q-D. Flow cytometry with antibodies against the human insulin receptor indicated the presence of Q-397, Q-418, and wild-type human insulin receptors in the surface of COS cells and failed to demonstrate a Q-D receptor. Insulin-induced autophosphorylation was similar in Q-397, Q-418, and wild-type human insulin receptors as was their ability to phosphorylate an artificial substrate, poly Glu-Tyr (4:1). Our inability to detect Q-D receptors was not caused by a lack of Q-D mRNA. COS cells transfected with Q-D cDNA generated as much Q-D mRNA as the amount of wild-type human insulin receptor mRNA present in cells transfected with wild-type receptor cDNA. Finally, pulse-chase experiments with [35S]Met were able to detect 190,000-Mr) proreceptors and the alpha-subunits for Q-397, Q-418, and wild-type human insulin receptors. In these experiments, Q-D-transfected cells produced a small amount of 170,000-Mr protein (presumably the Q-D proreceptor) that disappeared after 2 h and was not processed into α- and β-subunits. The marked discrepancy in the synthesis and/or processing of the single and double mutants suggests a functional redundancy that requires the presence of carbohydrates in a certain region of the receptor, but the precise location of the carbohydrates within the region can vary.
Skip Nav Destination
Article navigation
Original Articles|
July 01 1993
Glycosylation of Asn397 or Asn418 is Required for Normal Insulin Receptor Biosynthesis and Processing
William Bastian;
William Bastian
University of Rochester Medical Center, Departments of Medicine and Pathology
Rochester, New York
Search for other works by this author on:
Jian Zhu;
Jian Zhu
University of Rochester Medical Center, Departments of Medicine and Pathology
Rochester, New York
Search for other works by this author on:
Barbara Way;
Barbara Way
University of Rochester Medical Center, Departments of Medicine and Pathology
Rochester, New York
Search for other works by this author on:
Dean Lockwood;
Dean Lockwood
University of Rochester Medical Center, Departments of Medicine and Pathology
Rochester, New York
Search for other works by this author on:
James Livingston
James Livingston
University of Rochester Medical Center, Departments of Medicine and Pathology
Rochester, New York
Search for other works by this author on:
Address correspondence and reprint requests to Dr. Dean Lockwood, Parke-Davis Pharmaceutical, Research Division, 2800 Plymouth Road, Ann Arbor, Ml 48105.
Diabetes 1993;42(7):966–974
Article history
Received:
November 12 1992
Revision Received:
February 11 1993
Accepted:
February 11 1993
PubMed:
8513978
Citation
William Bastian, Jian Zhu, Barbara Way, Dean Lockwood, James Livingston; Glycosylation of Asn397 or Asn418 is Required for Normal Insulin Receptor Biosynthesis and Processing. Diabetes 1 July 1993; 42 (7): 966–974. https://doi.org/10.2337/diab.42.7.966
Download citation file:
56
Views